mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.4 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.4 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.4 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |